In summary, much work has been done to try to establish imaging tests as biomarkers and even "surrogate endpoints" for various angiogenesis therapies. However, initial results have been mixed (see articles by Galbraith and Padhani in this journal issue) probably due to a combination of factors the most important of which may be the lack of understanding of the biological and molecular basis for the different imaging phenotypes in different disease environments. With the increased scientific momentum in the field of agiogenesis, imaging scientists should strive to exploit both imaging and non-imaging tools so that the full potential of imaging can be realised.
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging